Core Viewpoint - Ameren reported quarterly earnings of $1.07 per share, slightly missing the Zacks Consensus Estimate of $1.08 per share, but showing an increase from $0.98 per share a year ago, indicating a -0.93% earnings surprise [1] - The company posted revenues of $2.1 billion for the quarter, exceeding the Zacks Consensus Estimate by 5.73% and up from $1.82 billion year-over-year [2] Earnings Performance - Over the last four quarters, Ameren has surpassed consensus EPS estimates only once [2] - The company had a previous quarter earnings expectation of $0.79 per share but reported $0.77, resulting in a -2.53% surprise [1] Stock Performance - Ameren shares have increased by approximately 11.3% since the beginning of the year, contrasting with the S&P 500's decline of -5.3% [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.97 for the upcoming quarter and $4.94 for the current fiscal year [7] - The Zacks Rank for Ameren is currently 3 (Hold), indicating expected performance in line with the market [6] Industry Context - The Utility - Electric Power industry is ranked in the top 14% of over 250 Zacks industries, suggesting a favorable environment for stocks in this sector [8] - Vistra Corp., another company in the same industry, is expected to report a significant year-over-year earnings increase of +134.8% for the quarter ended March 2025 [9]

Group 1: Earnings Performance - Monolithic Power (MPWR) reported quarterly earnings of $4.04 per share, exceeding the Zacks Consensus Estimate of $4 per share, and up from $2.81 per share a year ago, representing an earnings surprise of 1% [1] - The company posted revenues of $637.55 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.38%, and compared to year-ago revenues of $457.89 million [2] - Over the last four quarters, Monolithic has consistently surpassed consensus EPS and revenue estimates [2] Group 2: Stock Performance and Outlook - Monolithic shares have increased by approximately 0.2% since the beginning of the year, while the S&P 500 has declined by 5.3% [3] - The future performance of the stock will depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is $4.04 on revenues of $636.85 million, and for the current fiscal year, it is $16.97 on revenues of $2.64 billion [7] Group 3: Industry Context - The Semiconductor - Analog and Mixed industry, to which Monolithic belongs, is currently ranked in the top 38% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can impact stock performance [5][6]

DexCom (DXCM) came out with quarterly earnings of $0.32 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -3.03%. A quarter ago, it was expected that this medical device company would post earnings of $0.50 per share when it actually produced earnings of $0.45, delivering a surprise of -10%.Over the last four quarters, the comp ...

Stryker (SYK) came out with quarterly earnings of $2.84 per share, beating the Zacks Consensus Estimate of $2.73 per share. This compares to earnings of $2.50 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 4.03%. A quarter ago, it was expected that this medical device maker would post earnings of $3.87 per share when it actually produced earnings of $4.01, delivering a surprise of 3.62%.Over the last four quarters, the compan ...

Core Insights - Amazon reported quarterly earnings of $1.59 per share, exceeding the Zacks Consensus Estimate of $1.35 per share, and showing an increase from $1.13 per share a year ago, representing an earnings surprise of 17.78% [1] - The company generated revenues of $155.67 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.72% and up from $143.31 billion year-over-year [2] - Amazon has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Performance - The earnings surprise for the previous quarter was 22.37%, with actual earnings of $1.86 per share compared to an expected $1.52 per share [1] - The current consensus EPS estimate for the upcoming quarter is $1.33, with projected revenues of $160.46 billion, and for the current fiscal year, the EPS estimate is $6.13 on revenues of $690.33 billion [7] Stock Performance and Outlook - Amazon shares have declined approximately 15.9% since the beginning of the year, contrasting with the S&P 500's decline of 5.3% [3] - The company's Zacks Rank is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Internet - Commerce industry, to which Amazon belongs, is currently ranked in the top 37% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - Amgen reported quarterly earnings of $4.90 per share, exceeding the Zacks Consensus Estimate of $4.16 per share, and showing an increase from $3.96 per share a year ago, representing an earnings surprise of 17.79% [1][2] Financial Performance - The company achieved revenues of $8.15 billion for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 2.47%, and up from $7.45 billion year-over-year [2] - Over the last four quarters, Amgen has exceeded consensus EPS estimates four times and topped revenue estimates three times [2] Stock Performance - Amgen shares have increased approximately 11.6% since the beginning of the year, contrasting with a decline of -5.3% in the S&P 500 [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $5.29 on revenues of $8.82 billion, and for the current fiscal year, it is $20.57 on revenues of $34.99 billion [7] - The outlook for the Medical - Biomedical and Genetics industry is favorable, ranking in the top 32% of over 250 Zacks industries, suggesting potential for outperformance [8]

Group 1 - Cumulus Media reported a quarterly loss of $1.88 per share, which was worse than the Zacks Consensus Estimate of a loss of $1.29, and compared to a loss of $0.85 per share a year ago, indicating a significant earnings surprise of -45.74% [1] - The company posted revenues of $187.35 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 1.45%, and down from $200.05 million in the same quarter last year [2] - Cumulus shares have declined approximately 65.2% since the beginning of the year, contrasting with the S&P 500's decline of -5.3% [3] Group 2 - The earnings outlook for Cumulus is mixed, with the current consensus EPS estimate for the coming quarter at -$0.67 on revenues of $191.65 million, and -$3.21 on revenues of $776.2 million for the current fiscal year [7] - The Broadcast Radio and Television industry, to which Cumulus belongs, is currently ranked in the top 11% of over 250 Zacks industries, suggesting a favorable industry outlook [8] - TEGNA Inc., another company in the same industry, is expected to report quarterly earnings of $0.34 per share, reflecting a year-over-year decline of -24.4%, with revenues anticipated to be $677.17 million, down 5.2% from the previous year [9]

Core Viewpoint - Sotera Health Company reported quarterly earnings of $0.14 per share, exceeding the Zacks Consensus Estimate of $0.12 per share, and showing a slight increase from $0.13 per share a year ago, indicating a 16.67% earnings surprise [1][2] Financial Performance - The company posted revenues of $254.52 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 3.63%, compared to $248.18 million in the same quarter last year [2] - Over the last four quarters, Sotera Health has exceeded consensus EPS estimates two times and topped consensus revenue estimates three times [2] Stock Performance - Sotera Health shares have declined approximately 15.9% since the beginning of the year, while the S&P 500 has decreased by 5.3% [3] - The current Zacks Rank for Sotera Health is 3 (Hold), indicating expected performance in line with the market in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.19 on revenues of $283.2 million, and for the current fiscal year, it is $0.75 on revenues of $1.13 billion [7] - The outlook for the Medical Services industry, where Sotera Health operates, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable environment for stock performance [8]

Company Performance - Dun & Bradstreet reported quarterly earnings of $0.21 per share, exceeding the Zacks Consensus Estimate of $0.20 per share, and showing a year-over-year increase from $0.20 per share [1] - The company posted revenues of $579.8 million for the quarter ended March 2025, slightly missing the Zacks Consensus Estimate by 0.02%, but up from $564.5 million a year ago [2] - Over the last four quarters, Dun & Bradstreet has surpassed consensus EPS estimates only once and has topped consensus revenue estimates just once [2] Stock Movement and Outlook - Dun & Bradstreet shares have declined approximately 28% since the beginning of the year, compared to a decline of 5.3% for the S&P 500 [3] - The sustainability of the stock's price movement will largely depend on management's commentary during the earnings call [3] - The current consensus EPS estimate for the upcoming quarter is $0.24 on revenues of $595.09 million, and for the current fiscal year, it is $1.04 on revenues of $2.46 billion [7] Industry Context - The Business - Information Services industry, to which Dun & Bradstreet belongs, is currently ranked in the top 30% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - The current estimate revisions trend for Dun & Bradstreet is mixed, resulting in a Zacks Rank 3 (Hold), suggesting the stock is expected to perform in line with the market in the near future [6]

Huntington Ingalls (HII) came out with quarterly earnings of $3.79 per share, beating the Zacks Consensus Estimate of $2.90 per share. This compares to earnings of $3.87 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 30.69%. A quarter ago, it was expected that this shipbuilder would post earnings of $3.28 per share when it actually produced earnings of $3.15, delivering a surprise of -3.96%.Over the last four quarters, the co ...